Evidence map›Paper›PMID 30374076›Full record

ArticleScientific reports2018

Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine.

Jenni Puurunen, Katriina Tiira, Katariina Vapalahti, Marko Lehtonen, Kati Hanhineva, Hannes Lohi

Open access · goldAbstract readComparative Study
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Amino Acids in Dog Nutrition and Health.Advances in experimental medicine and biology · 2021
    Review
  12. Metabolome of canine and human saliva: a non-targeted metabolomics study.Metabolomics : Official journal of the Metabolomic Society · 2020
    Article
  13. Article
  14. Metabolomic Biomarkers in Anxiety Disorders.International journal of molecular sciences · 2020
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Jenni PuurunenDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Katriina TiiraDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-2253-8755
Katariina VapalahtiDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Marko LehtonenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Kati HanhinevaInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
Hannes LohiDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland. hannes.lohi@helsinki.fi.
University of Helsinki · FIUniversity of Eastern Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety-related disorders, including fearfulness are common and leading welfare problems among the worldwide dog population. The etiology of anxieties is complex and affected by genetic and environmental factors. Thus, there is a need for more comprehensive approaches, such as metabolomics, to understand the causes of anxiety and to identify anxiety-related biomarkers for more efficient diagnostic and treatment options. To study metabolic alterations related to canine fearfulness, a non-targeted plasma metabolite profiling was performed in a cohort of 20 fearful and 21 non-fearful dogs. The results showed that nine metabolic features were significantly associated with fearfulness. The most prominent change included increased plasma glutamine and γ-glutamyl glutamine (γ-Glu Gln) in fearful dogs across breeds. Alterations in glutamine metabolism have previously been associated with several psychiatric disorders, indicating the relevance of this finding also in dogs. In addition, we describe a novel breed-specific association between renal biomarker symmetric dimethylarginine (SDMA) and canine fearfulness. These observed metabolic alterations may result from high levels of prolonged psychological stress in fearful dogs.

Indexed as

AnimalsAnxietyArginineBehavior, AnimalBiomarkersBreedingDipeptidesDogsFearFemaleGlutamineMaleMetabolomeSpecies SpecificityArginineBiomarkersDipeptidesgamma-glutamylglutamineGlutaminesymmetric dimethylarginine

Identifiers

PMID30374076
PMCPMC6206014
OpenAlexW2896343097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.